Markets
Bristol-Myers Squibb Company (BMY)
BMYNYSEBiotechnology: Pharmaceutical Preparations
$62.43
+0.5800 (+0.94%) today
Closed, Nov 9, 4:00 PM ET
+0.94% 1D
- Market cap
- $127.02bn
- P/E
- 10.0
- EPS, last 4 quarters
- $6.23
- Dividend yield
- –
- Day range
- –
- 52-week range
- $45.27 to $68.64
- Average volume
- 11.54m
- Previous close
- $61.85
Analysts
20 coveringHold8 buy, 11 hold, 1 sell
Targets a year out average $65.74, +5.3% from here
$40.00now $62.43$80.00
Earnings
next estimate $1.56Next report
Dec 2025
+9.6%
Mar 2026
+9.7%
Jun 2026
+28.3%
Sep 2026
+11.6%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $12.50bn | $11.49bn | $12.97bn | $13.07bn |
| Gross profit | $8.40bn | $8.07bn | $9.25bn | $8.92bn |
| Operating income | $1.42bn | $3.27bn | $4.03bn | $2.85bn |
| Net income | $1.09bn | $2.68bn | $3.32bn | $2.16bn |
Last four quarters: revenue $50.03bn, margin 18.5%, free cash flow $9.29bn
News
8 latest- See Which Recent 13F Filers Hold BMY But Heritage Wealth Advisors ExitedBNK Invest · 6 hours ago
- Noteworthy ETF Outflows: SPYV, LMT, COF, BMYBNK Invest · 10 hours ago
- Will Bristol Myers' Growth Brands Offset Eliquis Headwinds?Zacks · 13 hours ago
- MRK's 2027 Outlook Challenging, Long-Term Prospects PromisingZacks · 13 hours ago
- Wall Street Is Ignoring Bristol Myers Squibb's Cash Machine -- and That's an Opportunity for Income InvestorsThe Motley Fool · 2 days ago
- Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?The Motley Fool · 2 days ago
- 3 High-Yield Healthcare Stocks to Buy With $1,000 and Hold Through Any MarketThe Motley Fool · 3 days ago
- MRK's Keytruda & Gardasil Sales Rise in Q3: Can the Momentum Last?Zacks · 5 days ago
The company
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- bms.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.